Plos Medicine
-
Publication Venue For
- Community-, facility-, and individual-level outcomes of a district mental healthcare plan in a low-resource setting in Nepal: A population-based evaluation.. 16:e1002748. 2019
- Deep learning for chest radiograph diagnosis: A retrospective comparison of the CheXNeXt algorithm to practicing radiologists.. 15:e1002686. 2018
- Development and validation of machine learning models to identify high-risk surgical patients using automatically curated electronic health record data (Pythia): A retrospective, single-site study.. 15:e1002701. 2018
- Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.. 15:e1002637. 2018
- Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.. 15:e1002607. 2018
- Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.. 15:e1002572. 2018
- Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.. 15:e1002482. 2018
- Research on HIV cure: Mapping the ethics landscape.. 14:e1002470. 2017
- Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.. 14:e1002435. 2017
- Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.. 14:e1002383. 2017
- Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis.. 14:e1002389. 2017
- Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.. 13:e1002136. 2016
- Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.. 13:e1002118. 2016
- Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.. 13:e1002124. 2016
- Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola.. 13:e1002042. 2016
- Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.. 12:e1001841. 2015
- Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.. 12:e1001823. 2015
- The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.. 11:e1001759. 2014
- HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission.. 11:e1001616. 2014
- Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial.. 11:e1001594. 2014
- Managing incidental genomic findings in clinical trials: fulfillment of the principle of justice.. 11:e1001584. 2014
- Reproductive and maternal health in the post-2015 era: cervical cancer must be a priority.. 10:e1001499. 2013
- Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.. 9:e1001290. 2012
- Informing the 2011 UN Session on Noncommunicable Diseases: applying lessons from the AIDS response.. 8:e1001086. 2011
- A research agenda to underpin malaria eradication.. 8:e1000406. 2011
- Air Pollution and the microvasculature: a cross-sectional assessment of in vivo retinal images in the population-based multi-ethnic study of atherosclerosis (MESA).. 7:e1000372. 2010
- Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.. 6:e1000107. 2009
- Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.. 6:e1000067. 2009
- Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease.. 6:e1000057. 2009
- The use of nonhuman primate models in HIV vaccine development.. 5:e173. 2008
- Improving defences at the portal of HIV entry: mucosal and innate immunity.. 5:e81. 2008
- Antibody-based HIV-1 vaccines: recent developments and future directions.. 4:e348. 2007
- Clinical trials and medical care: defining the therapeutic misconception.. 4:e324. 2007
- Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing.. 4:e249. 2007
- Gene expression signatures that predict radiation exposure in mice and humans.. 4:e106. 2007
- Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.. 4:e93. 2007
- Management of cryptococcosis: how are we doing?. 4:e47. 2007
- Metabolic profiling of patients with schizophrenia.. 3:e363. 2006
- Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B.. 3:e255. 2006
- Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria.. 3:e141. 2006
- Clinical trials registration.. 3:e157. 2006
- Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers.. 3:e47. 2006
- An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.. 3:e11. 2006
- Metabolic profiling of patients with schizophrenia.. 3. 2006
- Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.. 2:e313. 2005
- Inhibition of endothelial activation: a new way to treat cerebral malaria?. 2:e245. 2005
- Exercise and health: can biotechnology confer similar benefits?. 2:e68. 2005
- Should an institution that has commercial rights in a new drug or device be allowed to evaluate the technology?. 2:e9. 2005
- malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication. 14:e1002452-e1002452.